ASPIRO is the first multi-patient, multi-center clinical trial of an autologous cell therapy for Parkinson's disease. It is evaluating safety, tolerability, and preliminary efficacy of ANPD001 in ...
Public comments submitted to the Passenger Rail Authority about the Shenandoah Valley’s dormant rail corridor leaned heavily ...
Consulting has shifted from a discretionary expense to a structural requirement for companies trying to navigate AI-driven ...
Morning Overview on MSN
Disney+ and Netflix revive short-form video from a failed streaming app
Short, vertical video is no longer just the domain of social apps. By building TikTok-style feeds directly into their ...
How to Do It is Slate’s sex advice column. Have a question? Send it to Stoya and Rich here. It’s anonymous! Dear How to Do It ...
Meta's suite of three landmark agreements is poised to provide the financial certainty to extend aging plants, accelerate ...
Vanta reports on eight essential AI security best practices for organizations to mitigate risks and ensure safe AI adoption ...
Oil Price US on MSN
Lukoil’s Fire Sale and the New Era of Sanctions-by-Ownership
Lukoil’s asset sell-off has become a geopolitical operation, with Washington using OFAC rules and license deadlines to force ...
American whiskey is shifting from blistering growth to facing serious headwinds. Here are 11 macro-trends that will shape the ...
PRIME Marine has released a set of feature enhancements to its Vessel Management System, introducing CMS-aligned ...
At Tesla’s 2025 Annual Meeting, investors chose to evaluate strategy, incentives, and governance on their own terms.
Attorneys at Morgan Lewis discuss issues in e-discovery and information governance as companies adopt innovative data sources ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback